South Dakota Administrative Rules › Title 44 - Department of Health › Article 44:75 - Hospital, specialized Hospital critical access Hospital, and rural emergency Hospital facilities › Chapter 44:75:04 - Management and Administration › Section 44:75:04:09 - Tuberculin screening and testing requirements

Current through Register Vol. 51, page 10, July 15, 2024
Each facility shall develop criteria to screen healthcare
				  personnel for
Mycobacterium
tuberculosis (TB) based on the
				  Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel:
				  Recommendations from the National Tuberculosis Controllers Association and CDC,
				  2019. Each facility shall establish policies and procedures for conducting TB
				  risk assessments that include the key components of responsibility,
				  surveillance, and containment. The frequency of repeat screening depends upon
				  annual facility risk results.
Tuberculin screening requirements for healthcare personnel
				  are as follows:
(1) Each new
				healthcare personnel shall receive an initial individual TB risk assessment
				that is documented and the two-step method of tuberculin skin test or a TB
				blood assay test to establish a baseline within twenty-one days of employment.
				Any two documented tuberculin skin tests completed within twelve month period
				prior to the date of employment are considered two-step. A TB blood assay test
				completed within twelve month period prior to the date of employment or direct
				patient care is considered an adequate baseline test. Skin testing or TB blood
				assay tests are not necessary if a new healthcare personnel transfers from one
				licensed healthcare facility to another licensed healthcare facility within the
				state if the facility received documentation from the transferring healthcare
				facility or personnel, of the last skin or blood assay TB testing having been
				completed within the prior twelve months. Skin testing or TB blood assay test
				are not necessary if documentation is provided of a previous positive reaction
				to either test. Any healthcare personnel who has a newly recognized positive
				reaction to the skin test or TB blood assay test shall have a medical
				evaluation and a chest X-ray to determine the presence or absence of the active
				disease;
(2) Each healthcare
				personnel who provides documentation of a positive reaction to the tuberculin
				skin test or TB blood assay test must have a medical evaluation and chest X-ray
				to determine the presence or absence of the active disease;
(3) Each healthcare personnel with a history
				of a positive reaction to the tuberculin skin test or TB blood assay must be
				evaluated annually by a physician, physician assistant, nurse practitioner,
				clinical nurse specialist, or a nurse and a record maintained of the presence
				or absence of symptoms of TB. If this evaluation results in suspicion of active
				tuberculosis, the healthcare personnel must be referred for further medical
				evaluation to confirm the presence or absence of tuberculosis; and
(4) Each healthcare personnel identified at
				increased risk for TB because of an occupational risk or current or planned
				immunosuppression shall receive an annual TB risk screening.
General Authority:
SDCL
					 34-12-13(1)(5)(14),
					 34-22-9.
Law Implemented:
SDCL
					 34-12-13(1)(5)(14).
Tuberculosis Screening, Testing, and Treatment of U.S.
					 Health Care Personnel: Recommendations from the National Tuberculosis
					 Controllers Association and CDC, 2019. "Centers for Disease Control and
					 Prevention Morbidity and Mortality Weekly Report, May 17, 2019 / 68(19); pages
					 439-443. Copies are available at no cost at
https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a3.htm
.